Tadalafil
- Product NDC
- 71335-1823
- 11-digit product format
- 713351823
- Labeler code
- 71335
- Product ID
- 71335-1823_bb3b7333-03a8-465c-8845-7b9be87999af
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA209654
- Marketing category
- ANDA
- Marketing start
- 2019-03-26
- Substance
- TADALAFIL
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tadalafil
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TADALAFIL | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 742SXX0ICT |
| Rxcui | 757707 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-1823 | TADALAFIL TABLET [BRYANT RANCH PREPACK] | 102 | Current NDC, Legacy NDC, 4 package rows | 20231108_2c2ec257-06bc-4ca4-9cf3-d0f49980e374.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-1823-1 | 71335182301 | 90 TABLET in 1 BOTTLE (71335-1823-1) | 90 tablet | 2021-12-21 | 0000-00-00 | No | No | Current |
| 71335-1823-2 | 71335182302 | 30 TABLET in 1 BOTTLE (71335-1823-2) | 30 tablet | 2021-12-21 | 0000-00-00 | No | No | Current |
| 71335-1823-3 | 71335182303 | 10 TABLET in 1 BOTTLE (71335-1823-3) | 10 tablet | 2021-12-21 | 0000-00-00 | No | No | Current |
| 71335-1823-4 | 71335182304 | 20 TABLET in 1 BOTTLE (71335-1823-4) | 20 tablet | 2021-12-21 | 0000-00-00 | No | No | Current |